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Abstract 
 
Subarachnoid haemorrhage (SAH) is described throughout the literature as a devastating neurological 
disorder associated with significant mortality and morbidity rates, arising not just from the haemorrhage 
itself, but also as a result of the catastrophic multisystem sequelae that can accompany the condition.  
Rupture of an intracranial aneurysm accounts for up to 85% of instances of SAH, occurring in approximately 
6–7 per 100,000 in most populations and costing an estimated £510 million annually in the United Kingdom 
alone (Rivero-Arias et al, 2010).  Treatment of Aneurysmal Subarachnoid Haemorrhage (aSAH) includes 
prevention of re-bleeding, evacuation of space occupying haematomas, management of hydrocephalus and 
prevention of secondary cerebral insult.  Headache has been highlighted as the predominant, most 
characteristic and often the only symptom of aSAH, its severity having a variety of physiological and 
psychological effects on the patient.  This paper summarises the findings of a literature review conducted as 
part of a research study to examine existing practices in the assessment and management of headache in 
patients with aSAH in an Irish Neurosciences Centre.  The review demonstrates that despite a wealth of 
published literature on the diagnosis and management of aSAH, evaluation and management of its main 
symptom, headache, remains suboptimal and under-researched.  The lack of available literature 
demonstrates that such enquiry is both timely and necessary. 
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Key points 
 
Headache in the patient with aSAH is understudied, under-assessed and under-managed. This review 
highlights the need for further research to be undertaken into the effects that headache following aSAH has 
on the patient. This review also highlights the need for further research to be undertaken into how best to 
assess and treat headache following aSAH. 
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Subarachnoid haemorrhage (SAH) occurs when blood is forced from the cerebral vasculature into the 
subarachnoid space surrounding the brain. The cause for this, in up to 85% of cases, is rupture of an 
intracranial aneurysm—aSAH (Wilson et al, 2005; van Gijn et al, 2007). The rupture of an intracranial 
aneurysm constitutes a neurological emergency requiring expertise to assess and manage the many actual 
and potential neurological and systemic complications (Rabinstein et al, 2010). Risk of re-bleeding in patients 
with aSAH is approximately 40% (van Gijn et al, 2007) resulting in death or permanent disability in up to 80% 
of those patients. The goal in the management of patients with aSAH is therefore to evacuate space-
occupying haematomas, treat hydrocephalus and avert secondary cerebral injury as well as prevent 
rebleeding by securing the aneurysm (Beck et al, 2006; Randell et al, 2006). Even after the aneurysm is 
secured, the patient remains at risk of cerebral vasospasm, decreased cerebral perfusion and either 
localized, hemispheric or global cerebral ischaemia or infarction (Rabinstein et al, 2010). 
 
Headache is the predominant characteristic symptom of aSAH developing almost instantaneously at ictus in 
50% of cases and described by patients as sudden, severe and the ‘worst of their lives’ (Linn et al, 1998; 
Vermeulen and Schull, 2007; Bethel, 2010; Dorhout Mees et al, 2010). Such severity may have a variety of 
physiological and psychological effects on the patient, with the potential to negatively influence outcome. 
However, despite the potential adverse effects of headache pain on patients with aSAH, assessment and 
management of this common and enduring symptom remains suboptimal (Beydon et al, 2005; Binhas et al, 
2006). 
 
Significance of aneurysmal subarachnoid haemorrhage 
 
It is well documented that 10–15% of patients with aSAH die before reaching hospital, up to 50% die within a 
month, and of those who survive, 20–40% are left permanently disabled (Sen et al, 2003; Randell et al, 2006; 
Rinkel and Klijn, 2009). Indeed, despite improvements in diagnostic and treatment modalities, aSAH remains 
one of the main causes of death and disability in relatively young people, with an economic burden 
estimated to be in the region of 80 000 life years or £510 million annually in the UK alone (Rivero-Arias et al, 
2010). 
 
Important aspects of early medical care in aSAH include anti-emesis, blood pressure control, prevention of 
re-bleeding and secondary damage—all of which can be confounded by unrelieved pain such as headache 
(Rabinstein et al, 2010). Headache may increase physiological parameters such as intracranial pressure (ICP), 
blood pressure and heart rate, which may predispose the patient to re-bleeding episodes and consequently 
increase morbidity and mortality. However, while the significance of adequate headache assessment and 
management in the care of patients with aSAH may be apparent, it is a topic that the literature fails to 
adequately address. 
 
Search strategy 
 
To form a theoretical framework and conceptual background to place the study within the context of 
existing practices, a comprehensive literature search was conducted across a range of electronic databases 
including PubMed, CINAHL, EMBASE and the Cochrane Library. A combination of MeSH and keyword 
searching was used covering the topics of SAH, headache management, pain measurement and 
neuroscience nursing. Searches yielded high numbers of results on each topic individually, but when 
combined indicated that headache management was under-researched compared to diagnosis, surgical 
management, complications and outcomes for the aSAH patient. PubMed searches retrieved 19 692 articles 
on SAH; 54 280 articles on headache; 1406 articles contained both topics. The majority of these articles 
described headache in relation to SAH diagnosis. The use of subheadings such as ‘drug therapy’, ‘treatment’, 
‘therapeutic use’, ‘prevention’ and ‘control’ combined with ‘SAH and headache’, ‘pain’ and ‘analgesics’ when 
searching, reduced the results to 72 articles. 
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Two articles were identified that dealt specifically with aSAH and headache: Beydon et al (2005) and Binhas 
et al (2006). Both articles were published in Annales Francaises d’Anesthesie et de Reanimation, the journal 
of the French Society of Anaesthesia and Intensive Care. English language versions of the articles were not 
available as the journal only publishes in French. However, the primary author of each article kindly provided 
clarifications via email. Beydon et al (2005) conducted a literature review into the management of headache 
associated with SAH. They suggested that due to the paucity of empirical data, management strategies have 
had to be inferred from other areas of neurosurgery. It was proposed that the management of SAH is 
analogous to the management of traumatic brain injury, i.e. to restore an optimal homeostasis that 
analgesia and sedation facilitates while maintaining the clinical prerogatives of assessment and monitoring 
(Beydon et al, 2005). Binhas et al (2006) conducted a standardized postal survey into the assessment and 
management of pain associated with SAH. A questionnaire was sent to every senior doctor in every 
neuroscience intensive care unit in France to evaluate: 
• How pain was assessed 
• The type of analgesia used and method of administration 
• The individuals’ opinion regarding efficacy of pain management or lack thereof 
The authors concluded that the majority of centres considered the assessment and management of 
headache associated with SAH to be inadequate and unsatisfactory. In contrast to Ireland, the majority of 
neuroscience centres in the study used morphine in their treatment regimen. The generalizability of results 
may be somewhat limited, however, due to the study setting (intensive care units only), questionnaire 
design (closed ended questions) and statistical analysis employed (descriptive only). 
 
The search criteria were then broadened to include post-operative pain management and perceptions of 
headache pain in other categories of patients. Searches on nurse and patient perceptions of pain were 
conducted in PsycInfo and CINAHL. Broader results were found in this way, and given the limited information 
available for critical review regarding headache control in the aSAH patient, general concepts were 
extrapolated for our study including: 
• The effect of pain on the patient 
• Assessment and documentation of pain 
• Analgesia provision: attitudes and agents 
 
The effect of pain on the patient 
 
Pain is a subjective, multifaceted phenomenon influenced by a number of factors including past experience 
of pain, culture, expectations and the context in which the person experiences pain (Bourbonnais et al 2004; 
Whelan et al, 2004). The patient can be affected physically and psychologically in general terms and may 
experience anxiety, fear, loss of sleep, fatigue, altered mental status, nausea and vomiting, hypertension, 
tachypnoea and tachycardia, depression, immobility, prolonged recovery time and increased length of 
hospital stay (Leith, 1998; Hader and Guy, 2004; McLafferty and Farley, 2008). Conversely, adequate 
analgesia may lead to improved cardiovascular functioning, decreased pulmonary comorbidity and mortality, 
earlier ambulation, decreased likelihood of deep vein thrombosis and improved patient outcomes (Leith, 
1998). 
 
Untreated pain can increase sympathetic activity leading to systemic hypertension, increased cerebral blood 
flow, oxygen consumption and intracranial pressure in patients with compromised cerebral autoregulation. 
Hypertension also increases the risk of re-bleeding (Leith, 1998) and can exacerbate the symptoms of SAH 
(Bethel, 2010). Such corollaries can have a deleterious effect on the patient with aSAH in whom headache 
may last for up to 2 weeks (Dorhout Mees et al, 2010). Despite the numerous potential adverse effects 
uncontrolled headache may have, and the range of treatment options and approaches available, pain 
management remains a significant problem (Hader and Guy, 2004) and is understudied in the context of 
headache associated with aSAH (Binhas et al, 2006). 
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Assessment and documentation of pain 
 
Adequate assessment and management of headache is important in the aSAH patient due to the variety of 
potential problems that untreated headache and elevated ICP can cause (Cook, 2008). However, part of the 
problem of assessing and monitoring pain is related to the assessment and documentation techniques 
themselves, as pain cannot be said to be relieved unless it has been accurately measured (Wallace et al, 
1999). The Agency for Health Care Policy and Research (1992) suggested that the absence of pain behaviours 
does not negate the presence of pain. Indeed, Binhas et al (2006) called for the development of a validated 
pain rating scale specifically aimed at SAH, because over half of the neurosurgical centres participating in 
their study sub-optimally assessed and managed pain in patients with SAH. Such results have been mirrored 
across a variety of clinical settings with many authors agreeing that the evaluation and treatment of pain is 
both unsystematic and inadequate despite technological advances, substantial research into the area and 
the existence of effective pain relief strategies (Chung and Lui, 2003; Kim et al, 2005; Dihle et al, 2006; 
Richards and Hubbert, 2007; Ene et al, 2008; Bell and Duffy, 2009). 
 
Helfand and Freeman (2009) suggested that pain assessment tools must be simple to administer, easy for 
patients to understand and responsive to changes in pain over time. One such scale is the visual analogue 
scale (VAS). Linear and horizontal VASs have been shown to be equally valid for registry of pain intensity in 
conscious patients with headache pain (although not specifically aSAH headache) and non-headache pain 
(Lundqvist et al, 2009). Myles et al (1999) concluded that the VAS is linear for mild-to-moderate pain with 
changes in the VAS score representing a relative change in the magnitude of pain sensation. Further study is 
required to assess the validity and reliability of the VAS in aSAH patients. 
 
Analgesia provision: attitudes and agents 
 
There are many factors that contribute to ineffective analgesia provision such as inadequate prescribing, 
workload and organizational constraints, attitudes and beliefs regarding pain assessment and management, 
cultural factors, lack of time, or staffing shortages (Schafheutle et al, 2001; Chung and Lui, 2003; Sloman et 
al, 2005; Klopper et al, 2006; Bell and Duffy, 2009). Ene et al (2008) suggested that while nurses may have 
theoretical knowledge about pain management, this does not necessarily mean that they will successfully 
implement such knowledge into clinical practice. Nurses can underestimate patients’ pain or believe that 
patients should not expect complete pain relief. Tasks such as answering the phone, looking for equipment, 
participating in doctors’ rounds, assisting colleagues or attending to the business of the ward can often be 
prioritized over analgesia provision (Manias et al, 2002; Dihle et al, 2006). Patients can therefore be 
reluctant to distract a nurse by asking for pain relief again for fear of being regarded as a ‘nuisance’ or a 
‘problem patient’, with more than half of patients being passive recipients of analgesia (Manias et al, 2006). 
 
However, nurses have a professional, moral and ethical responsibility to make conscientious efforts to 
relieve patient suffering by providing adequate analgesia (Leith, 1998). In the context of aSAH headache, this 
can be difficult to achieve and often necessitates a polypharmacy approach to pain management. The 
literature frequently ‘recommends’ the use of paracetamol, codeine, tramadol or other opiate-based 
analgesia for controlling headache pain associated with aSAH without suggesting if such recommendations 
are based on anecdotal, consensual or empirical evidence (Cook, 2008; Rinkel and Klijn, 2009; Bethel, 2010). 
Beydon et al (2005) suggest that while paracetamol should be used in the treatment regime, it will not in 
itself be sufficient to control aSAH headache and other agents will be required. Codeine phosphate is a 
commonly used analgesic following craniotomy and aSAH. However, Roberts (2004) argued that codeine 
phosphate is an unpredictable pro-drug that does not equate to a safe and effective method of providing 
analgesia with efficacy dependant on the amount of active metabolite formed. 
 
While morphine is often the drug of choice for post-operative patients, its use has been limited in the 
neurosurgical patient due to two main assumptions - that craniotomy patients suffer a low incidence and 
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severity of postoperative pain, and fear that opioid side-effects may mask neurological deterioration 
(Herbert, 2001; Roberts, 2004). Such assumptions are further validated by anecdotal evidence, exclusion of 
the subject from the literature and the discrepancies found among neurosurgical centres in the type of 
analgesia provided to patients with aSAH (Binhas et al, 2006). However, Roberts (2004) suggested that 
morphine is efficacious and does not hold the inherent risks attributed to it if administered under close 
observation in a high dependency unit by knowledgeable practitioners. Furthermore, Rinkel and Klijn (2009) 
proposed that those patients with aSAH whose headache remains severe should be treated with opiates. 
Doses should be titrated and patients observed to minimize the risk of overdose and maximize analgesic 
effect (Roberts, 2004; Binhas et al, 2006; Randell et al, 2006).  In addition, when considering any form of 
therapeutic intervention, a risk-benefit calculation should be undertaken and the potential risks of 
withholding analgesia compared to those of administering. The ideal analgesic should provide sufficient 
analgesia to relieve moderate to severe headache pain whilst not masking symptoms of neurological 
deterioration or producing adverse side effects (Linn et al, 1998; Roberts, 2004; Binhas et al, 2006; Randell et 
al, 2006). 
 
Discussion 
 
There is a paucity of empirical evidence to critically discuss headache management in the aSAH patient. 
Most of the literature on the subject describes the severity and suddenness of onset of headache.  
Guidelines published by the American Heart Association (Bederson et al, 2009) regard the clinical 
presentation of aSAH headache as one of the most distinctive in medicine, yet headache management is not 
addressed. Those articles that do suggest management strategies fail to offer rationale for their choice of 
analgesia.  Conclusions regarding analgesia in other clinical specialities and from other areas of neurosurgery 
such as post-craniotomy and traumatic brain injury can be extrapolated to the aSAH patient but to a vast 
extent they remain rational conjecture. There is no excuse for poor pain management (Haigh, 2008). 
 
Conclusion 
 
Although pain assessment and management are generally well explored concepts in nursing research, 
findings from empirical studies have not been implemented resulting in an inadequate and inconsistent 
approach to pain care (Gordon et al, 2002; Bell and Duffy, 2009). Specifically, there is a lack of empirical data 
regarding headache control in the aSAH patient from both a national and an international perspective. The 
literature that is available suggests that the assessment and management of headache associated with aSAH 
is suboptimal, without consensus and inconsistent with a clear need to develop a well-validated pain rating 
scale dedicated to aSAH patients (Binhas et al, 2006). While extrapolations can be made regarding analgesia 
within other areas of neurosurgery, concerns for maintaining the neurological integrity of the patient exist.  
This literature review has raised many questions that have informed our research study: 
 
• Are patients with aSAH currently being adequately assessed for headache in the study hospital? 
• How is this assessment documented and communicated? 
• What changes to assessment and documentation techniques, if any, need to be made? 
• What is the current analgesia regime in the study hospital with regard to patients with aSAH? 
• Is this regime effective? 
• What are the barriers to effective headache control in the patient with aSAH? 
• What benchmarks, guidelines, standard operating procedures or total quality management / continuous 
quality improvement processes or initiatives are in place to ensure effective headache pain management in 
the study hospital and internationally? 
• What is a reliable and valid method of pain assessment in the patient with aSAH? 
 
Therefore, additional studies addressing the management of headache in aSAH are required to increase the 
knowledge base, and allow health professionals to make informed decisions. 
 
 6
REFERENCES 
 
Agency for Health Care Policy and Research Acute Pain Management Guideline Panel (1992) Acute Pain Management in Adults: 
Operative Procedures: Quick Reference Guide for Clinicians. http://archive.ahrq. gov/clinic/medtep/acute.htm  
 
Beck J, Raabe A, Szelenyi A et al (2006) Sentinel headache and the risk of rebleeding after aneurysmal subarachnoid haemorrhage. 
Stroke 37(11): 2733–7  
 
Bederson JB, Connolly ES, Batjer HH et al (2009) Guidelines for the management of aneurysmal subarachnoid haemorrhage: A 
statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 40(3): 
994–1025  
 
Bell L, Duffy A (2009) Pain assessment and management in surgical nursing: a literature review. Br J Nurs 18(3): 153–6  
 
Bethel J (2010). Subarachnoid haemorrhage: case study and literature review. Emerg Nurse 18(1): 22–6  
 
Beydon L, Audibert G, Berré J et al (2005) [Pain management in severe subarachnoid haemorrhage.] Ann Fr Anesth Reanim 24(7): 
782–6  
 
Binhas M, Walleck P, El Bitar N et al (2006) [Pain management in subarachnoid haemorrhage: a survey of French analgesic practices.] 
Ann Fr Anesth Reanim 25(9): 935–9  
 
Bourbonnais FF, Perreault A, Bouvette M (2004) Introduction of a pain and symptom assessment tool in the clinical setting: lessons 
learned. J Nurs Manag 12(3): 194–200  
 
Chung JW, Lui JC (2003) Postoperative pain management: study of patients’ level of pain and satisfaction with health care providers’ 
responsiveness to their reports of pain. Nurs Health Sci 5(1): 13–21  
 
Cook NF (2008) Emergency care of the patient with subarachnoid haemorrhage. Br J Nurs 17(10): 624–9  
 
Dihle A, Bjølseth G, Helseth S (2006) The gap between saying and doing in postoperative pain management. J Clin Nurs 15(4): 469–79  
 
Dorhout Mees SM, Bertens D, van der Worp HB et al (2010) Magnesium and headache after aneurysmal subarachnoid haemorrhage. 
J Neurol Neurosurg Psychiatry 81(5): 490–3  
 
Ene KW, Nordberg G, Bergh I et al (2008) Postoperative pain management – the influence of surgical ward nurses. J Clin Nurs 17(15): 
2042–50  
 
Gordon DB, Pellino TA, Miaskowski C et al (2002) A 10 year review of quality improvement monitoring in pain management: 
recommendations for standardized outcome measures. Pain Manag Nurs 3(4): 116–30  
 
Hader CF, Guy J, (2004) Your hand in pain management. Nurs Manage 35(11): 21–7  
 
Haigh C (2008) This might hurt… a reflection on pain management in the 21st century. J Clin Nurs 17(15): 1961–2  
 
Helfand M, Freeman M (2009) Assessment and management of acute pain in adult medical inpatients: a systematic review. Pain Med 
10(7): 1183–99  
 
Herbert C (2001) Use of morphine for pain after intracranial surgery. Prof Nurse 16(4): 1029–33  
 
Kim HS, Schwartz-Barcott D, Tracey SM et al (2005) Strategies of pain assessment used by nurses on surgical units. Pain Manag Nurs 
6(1): 3–9  
 
Klopper H, Andersson H, Minkkinen M et al (2006) Strategies in assessing postoperative pain – a South African study. Intensive Crit 
Care Nurs 22(1): 12–21  
 
Leith B (1998) Pharmacological management of pain after intracranial surgery. J Neurosci Nurs 30(4): 220–4  
 
Linn FH, Rinkel GJ, Algra A et al (1998) Headache characteristics in subarachnoid haemorrhage and benign thunderclap headache. J 
Neurol Neurosurg Psychiatry 65(5): 791–3  
 
Lundqvist C, Benth JS, Grande RB et al (2009) A vertical VAS is a valid instrument for monitoring headache pain intensity. Cephalalgia 
29(10): 1034–41  
 7
 
Manias E, Botti M, Bucknall T (2002) Observation of pain assessment and management – the complexities of clinical practice. J Clin 
Nurs 11(6): 724–33  
 
Manias E, Botti M, Bucknall T (2006) Patients’ decision-making strategies for managing postoperative pain. J Pain 7(6): 428–37  
 
McLafferty E, Farley A (2008) Assessing pain in patients. Nurs Stand 22(25): 42–6  
 
Myles PS, Troedel S, Boquest M et al (1999) The pain visual analog scale: is it linear or nonlinear? Anesth Analg 89(6): 1517–20  
 
Rabinstein AA, Lanzino G, Wijdicks EF (2010) Multidisciplinary management and emerging therapeutic strategies in aneurysmal 
subarachnoid haemorrhage. Lancet Neurol 9(5): 504–19  
 
Randell T, Niemelä M, Kyttä J et al (2006) Principles of neuroanesthesia in aneurysmal subarachnoid hemorrhage: The Helsinki 
experience. Surg Neurol 66(4): 382–8  
 
Richards J, Hubbert AO (2007) Experiences of expert nurses in caring for patients with postoperative pain. Pain Manag Nurs 8(1): 17–
24  
 
Rinkel GJ, Klijn CJ (2009) Prevention and treatment of medical and neurological complications in patients with aneurysmal 
subarachnoid haemorrhage. Pract Neurol 9(4): 195–209  
 
Rivero-Arias O, Gray A, Wolstenholme J (2010) Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the 
United Kingdom. Cost Eff Resour Alloc 8:6  
 
Roberts G (2004) A review of the efficacy and safety of opioid analgesics post-craniotomy. Nurs Crit Care 9(6): 277–83  
 
Schafheutle EI, Cantrill JA, Noyce PR (2001) Why is pain management suboptimal on surgical wards? J Adv Nurs 33(6): 728–37  
 
Sen J, Belli A, Albon H et al (2003) Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol 
2(10): 614–21  
 
Sloman R, Rosen G, Rom M et al (2005) Nurses’ assessment of pain in surgical patients. J Adv Nurs 52(2): 125– 
32  
 
van Gijn J, Kerr RS, Rinkel GJ (2007) Subarachnoid Haemorrhage. Lancet 369(9558): 306–18  
 
Vermeulen MJ, Schull MJ, (2007) Missed diagnosis of subarachnoid hemorrhage in the emergency department. Stroke 38(4): 1216–
21  
 
Wallace KG, Graham KM, Bacon DR et al (1999) The development and testing of the Patient Record Pain Management Assessment 
Tool. J Nurs Care Qual 13(4): 34–46  
 
Whelan CT, Jin L, Meltzer D (2004) Pain and satisfaction with pain control in hospitalized medical patients: no such thing as low risk. 
Arch Intern Med 164(2): 175–80  
 
Wilson SR, Hirsch NP, Appleby I (2005) Management of subarachnoid haemorrhage in a non-neurosurgical centre. Anaesthesia 60(5): 
470–85  
 
    
